Loading company…
Myoridge Co. Ltd., based in Kyoto, develops cell culture media for mesenchymal stem cells and T cells.
Founded in 2016 in Kyoto-shi, Japan, Myoridge Co. Ltd. sells proprietary cell culture media and consulting services to pharmaceutical, biotech and academic research clients in Japan, the United States and Europe. Its flagship products include the patented CarmyA-Monkey media and Ex-iPS Cell Medium. On April 25, 2022, it raised JPY 600 million in a Series D round led by Mitsubishi Chemical Group, Sumitomo Chemical and TOPPAN Holdings.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in